The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQFI.L Regulatory News (QFI)

  • There is currently no data for QFI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Utah Project Update

23 Sep 2021 07:00

RNS Number : 7355M
Quadrise Fuels International PLC
23 September 2021
 

23 September 2021

 

Quadrise Fuels International plc

("Quadrise", "QFI", the "Company" and together with its subsidiaries the "Group")

 

Utah Project Update

 

Quadrise, the supplier of MSAR® and bioMSAR™ emulsion technology and fuels, the low-cost, cleaner alternatives to heavy fuel oil and biofuels, is pleased to provide an update on the testing of a produced oil sample taken from the Petroteq Oil Sands Plant ("POSP") from the Greenfield Energy LLC's ("Greenfield") Utah operations team.

 

An extensive programme of testing on the Greenfield oil sample was completed at the Quadrise Research Facility ("QRF") in Essex on schedule.

 

The testing programme at QRF has confirmed the ability to produce commercial MSAR® and bioMSAR™ fuels from the sample of heavy sweet oil provided and a report of the testing results has now been issued to the client. Simulations of storage and handling of both MSAR® and bioMSAR™ produced were also completed during the programme which indicate that commercial production of MSAR® and bioMSAR™ fuels would be possible in Utah for potential power and marine end-user applications domestically and internationally.

 

This testing programme concludes the Proof-of-Concept work that was scheduled in Phase 1 of the Commercial Trial Agreement announced on 18 August 2020 and Quadrise and Greenfield are now in discussions regarding potential future trials and deployment of the technology to produce MSAR® and/or bioMSAR™ fuel at commercial scale.

 

Further announcements will be made, as appropriate, in due course.

 

Jason Miles, CEO of Quadrise, said:

 

"We are pleased to have completed the testing and analysis work during August as scheduled and to be reporting the positive results to Greenfield. We look forward to updating Quadrise shareholders in due course as to the next steps for this exciting low-sulphur MSAR® and bioMSAR™ opportunity in Utah, once agreed with Greenfield and their strategic partners."

For further information, please contact:

Quadrise Fuels International Plc

 

Mike Kirk, Chairman

+44 (0)20 7031 7321

Jason Miles, Chief Executive Officer

ir@quadrisefuels.com

 

 

Nominated Adviser

 

Cenkos Securities plc

 

Ben Jeynes

Katy Birkin

+44 (0)20 7397 8900

 

 

Joint Brokers

 

Peel Hunt LLP

 

Richard Crichton

+44 (0)20 7418 8900

David McKeown

 

 

 

Shore Capital Stockbrokers Limited

 

Toby Gibbs

Fiona Conroy

+44 (0)20 7408 4090

 

Public & Investor Relations

 

FTI Consulting

 

Ben Brewerton

+44 (0)20 3727 1000

Ntobeko Chidavaenzi

 

 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014 (as amended), which forms part of domestic UK law pursuant to the European Union (Withdrawal) Act 2018. Upon publication of this announcement via a Regulatory Information Service, this inside information is now considered to be in the public domain.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEASNDAAKFEEA
Date   Source Headline
12th Aug 20154:35 pmRNSPrice Monitoring Extension
29th Jul 20154:40 pmRNSSecond Price Monitoring Extn
29th Jul 20154:35 pmRNSPrice Monitoring Extension
21st Jul 20154:35 pmRNSPrice Monitoring Extension
25th Jun 20154:40 pmRNSSecond Price Monitoring Extn
25th Jun 20154:35 pmRNSPrice Monitoring Extension
5th Jun 20154:35 pmRNSPrice Monitoring Extension
1st Apr 20151:52 pmRNSHolding(s) in Company
30th Mar 20157:00 amRNSHalf Yearly Report
20th Mar 20154:41 pmRNSSecond Price Monitoring Extn
20th Mar 20154:35 pmRNSPrice Monitoring Extension
16th Feb 20157:00 amRNSNotice of Interim Results and Business Update
13th Feb 201510:55 amRNSStmnt re Share Price Movement
9th Feb 20154:13 pmRNSHolding(s) in Company
30th Jan 201511:40 amRNSDirector's Dealing and Issue of Equity
19th Jan 20154:35 pmRNSPrice Monitoring Extension
16th Jan 20154:40 pmRNSSecond Price Monitoring Extn
16th Jan 20154:35 pmRNSPrice Monitoring Extension
12th Jan 20154:40 pmRNSSecond Price Monitoring Extn
12th Jan 20154:35 pmRNSPrice Monitoring Extension
7th Jan 20157:00 amRNSPersonnel Update
18th Dec 20147:00 amRNSProgramme Update and Purchase of MSAR MMUs
3rd Dec 20142:00 pmRNSHolding(s) in Company
3rd Dec 201411:15 amRNSDirector/PDMR Shareholding
3rd Dec 201410:45 amRNSHolding(s) in Company
28th Nov 20143:50 pmRNSResult of AGM
10th Nov 20147:00 amRNSCo-operation and Exclusive Supply Agreement
31st Oct 20147:00 amRNSTotal Voting Rights
22nd Oct 20143:12 pmRNSAcquisition of Minority Interest, Issue of Equity
20th Oct 20147:00 amRNSFinal Results
10th Oct 20142:33 pmRNSAppointment of Executive Director
8th Oct 201412:34 pmRNSDirectorate Change
11th Sep 20147:00 amRNSHolding(s) in Company
9th Jul 201412:20 pmRNSHolding(s) in Company
3rd Jul 20147:22 amRNSHalf Year Update on Active Programmes
30th May 20147:00 amRNSTotal Voting Rights
9th May 20142:45 pmRNSDirector/PDMR Shareholding
7th May 20142:25 pmRNSIssue of Equity
30th Apr 20147:00 amRNSTotal Voting Rights
17th Apr 20143:41 pmRNSChange of Shareholding
15th Apr 20144:40 pmRNSSecond Price Monitoring Extn
15th Apr 20144:35 pmRNSPrice Monitoring Extension
8th Apr 20144:35 pmRNSPrice Monitoring Extension
2nd Apr 20142:04 pmRNSIssue of Options and Director's Dealing
31st Mar 20147:00 amRNSTotal Voting Rights
25th Mar 201410:27 amRNSDirector/PDMR Shareholding
24th Mar 20147:00 amRNSHalf Yearly Report
6th Mar 20147:00 amRNSIssue of Equity
24th Feb 20147:00 amRNSUpdate on active programmes
24th Feb 20147:00 amRNSRoyalty Agreement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.